Back to Agenda
SS03 Preparing for the Next Pandemic and Improving Public and Patient Understanding of Product Information: 2030 at the Global Level and What to Think Now
Session Chair(s)
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Tse Siang Kang, PhD
Pfizer Pte Ltd, Singapore
Head of Regulatory Affairs, North, East, West Asia, Global Regulatory
Yoshihiro Aoyagi, MS
National Cancer Center Hospital East, Japan
Manager, Department of Medical Information
Have an account?